Q3 2024 Holdings
Filed 2024-11-14 | 67 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| AC Immune SA(ACIU) | SHS | H00263105 | $375.4K | 99,313 | 0.0% |
| Affimed N V | ORDINARY SHS NEW | N01045207 | $559.3K | 166,460 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $639.2K | 52,006 | 0.0% |
| Aerovate Therapeutics Inc | COM | 008064107 | $1.0M | 485,141 | 0.1% |
| Absci Corporation(ABSI) | COM | 00091E109 | $1.0M | 272,869 | 0.1% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $1.4M | 137,949 | 0.1% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $1.5M | 406,558 | 0.1% |
| Alector Inc(ALEC) | COM | 014442107 | $1.6M | 332,756 | 0.1% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $1.8M | 313,780 | 0.1% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $2.1M | 3,309,309 | 0.1% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $2.2M | 84,380 | 0.1% |
| Inflarx NV(IFRX) | COM | N44821101 | $2.5M | 1,621,787 | 0.2% |
| Xoma Royalty Corporation(XOMA) | COM NEW | 98419J206 | $2.5M | 94,289 | 0.2% |
| Maravai Lifesciences Hldgs I(MRVI) | COM CL A | 56600D107 | $2.8M | 336,966 | 0.2% |
| Iqvia Hldgs Inc(IQV) | COM | 46266C105 | $3.1M | 13,138 | 0.2% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $3.2M | 777,890 | 0.2% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $3.2M | 190,531 | 0.2% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $3.3M | 135,219 | 0.2% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $3.3M | 1,293,257 | 0.2% |
| Staar Surgical Co(STAA) | COM PAR $0.01 | 852312305 | $3.4M | 91,199 | 0.2% |
| Merus N V | COM | N5749R100 | $3.4M | 68,258 | 0.2% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $3.6M | 10,588 | 0.2% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $3.8M | 192,398 | 0.3% |
| Icon PLC(ICLR) | SHS | G4705A100 | $3.9M | 13,668 | 0.3% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $4.1M | 535,405 | 0.3% |
| Avantor Inc(AVTR) | COM | 05352A100 | $4.4M | 168,369 | 0.3% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $4.6M | 5,547,880 | 0.3% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $4.7M | 998,079 | 0.3% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $4.9M | 4,978,458 | 0.3% |
| Paragon 28 Inc(FNAUSD) | COM | 69913P105 | $5.0M | 749,213 | 0.3% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $5.1M | 307,357 | 0.3% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $5.8M | 861,268 | 0.4% |
| Sutro Biopharma Inc | COM | 869367102 | $6.4M | 1,841,989 | 0.4% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $6.4M | 693,263 | 0.4% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $6.6M | 132,537 | 0.5% |
| Evolus Inc(EOLS) | COM | 30052C107 | $7.3M | 453,061 | 0.5% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $9.1M | 124,491 | 0.6% |
| Fortrea Hldgs Inc(FTRE) | COMMON STOCK | 34965K107 | $9.2M | 457,967 | 0.6% |
| Elevance Health Inc(ELV) | COM | 036752103 | $10.1M | 19,465 | 0.7% |
| Centene Corp del(CNC) | COM | 15135B101 | $10.2M | 134,959 | 0.7% |
| Danaher Corporation(DHR) | COM | 235851102 | $10.7M | 38,429 | 0.7% |
| Humana Inc(HUM) | COM | 444859102 | $10.7M | 33,860 | 0.7% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $12.2M | 869,913 | 0.8% |
| Bausch Health COS Inc(BHC) | COM | 071734107 | $12.5M | 1,530,914 | 0.9% |
| Mannkind Corp(MNKD) | COM NEW | 56400P706 | $12.5M | 1,992,504 | 0.9% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $15.7M | 691,232 | 1.1% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $18.9M | 471,355 | 1.3% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $19.2M | 564,902 | 1.3% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $20.0M | 445,204 | 1.4% |
| Viatris Inc(VTRS) | COM | 92556V106 | $20.0M | 1,726,354 | 1.4% |